The effect of chloroquine, hydroxychloroquine OR ivermectin in patients with severe manifestations of coronavirus : Phase II study on chloroquine and hydroxychloroquine in patients with manifestationsserious cases of COVID-19 infection

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 29. Mai Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Coronavirus, non specifed location coronavirus infection;b34.2
Recruitment Status: Completed
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 02-10-2020, Last updated: 2023-06-05

ICTRP ID:

RBR-8h7q82

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO007155018